THG to acquire Biossance from Amyris for $20m.

THG, an online retailer, to acquire Biossance, a prestige skincare brand, from Amyris, a biotechnology company, for $20m. "We are delighted to acquire the pre-eminent skincare brand Biossance. The technology-led, clean chemistry formulations resonate with consumers globally, evidenced by a strong performance on our own retail sites. We have significant experience in prestige skincare as an innovator and manufacturer, and through our own brand portfolio including Perricone MD and ESPA. We're incredibly fortunate and excited to secure this opportunity to work with the Biossance team and further build on the brand's strong awareness across the US," Matthew Moulding, THG CEO.